Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Sciclone Pharmaceut (SCLN)

Sciclone Pharmaceut (SCLN)
11.15 unch (unch) 10/13/17 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Fri, Oct 13th, 2017
Day Low
11.15
Day High
11.20
Open 11.15
Previous Close 11.15 11.15
Volume 2,224,600 2,224,600
Avg Vol 493,170 493,170
Stochastic %K 66.67% 66.67%
Weighted Alpha +13.70 +13.70
5-Day Change unch (unch) unch (unch)
52-Week Range 8.55 - 11.43 8.55 - 11.43
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 581,918
  • Shares Outstanding, K 52,190
  • Annual Sales, $ 160,100 K
  • Annual Income, $ 30,730 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.72
  • Price/Sales 3.63
  • Price/Cash Flow 14.83
  • Price/Book 2.31
  • Price/Earnings ttm 12.25
  • Earnings Per Share ttm 0.91
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/08/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/17
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.19
  • Growth Rate Est. (year over year) +525,689.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.02 +1.13%
on 09/15/17
Period Open: 11.10
11.20 -0.45%
on 10/13/17
+0.05 (+0.45%)
since 09/13/17
3-Month
10.90 +2.29%
on 08/02/17
Period Open: 10.93
11.43 -2.41%
on 08/03/17
+0.22 (+2.06%)
since 07/13/17
52-Week
8.55 +30.41%
on 10/28/16
Period Open: 10.02
11.43 -2.41%
on 08/03/17
+1.13 (+11.28%)
since 10/13/16

Business Summary

Sciclone Pharmaceuticals, Inc. develops and commercializes novel medicines for treating a broad range of the world's most serious diseases. They have focused their current product development and commercial activities on the following diseases: hepatitis C, hepatocellular carcinoma, malignant melanoma,...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 11.22
1st Resistance Point 11.18
Last Price 11.15
1st Support Level 11.13
2nd Support Level 11.12
3rd Support Level N/A

See More

52-Week High 11.43
Last Price 11.15
Fibonacci 61.8% 10.33
Fibonacci 50% 9.99
Fibonacci 38.2% 9.65
52-Week Low 8.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective